Pulmonary function in children with systemic lupus erythematosus

被引:12
|
作者
Cerveri, I
Fanfulla, F
Ravelli, A
Zoia, MC
Ramenghi, B
Spagnolatti, L
Villa, I
Martini, A
机构
[1] UNIV PAVIA,INST RESP DIS,I-27100 PAVIA,ITALY
[2] UNIV PAVIA,DEPT PEDIAT,I-27100 PAVIA,ITALY
[3] UNIV PAVIA,IRCCS S MATTEO,I-27100 PAVIA,ITALY
关键词
systemic lupus erythematosus; pulmonary function tests;
D O I
10.1136/thx.51.4.424
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background - Abnormalities of pulmonary function have been found in children with systemic lupus erythematosus (SLE) even in the absence of clinical or radiographic evidence of pulmonary involvement. It is unknown whether these abnormalities represent an early sign of progressive lung disease or whether they are associated with disease activity. Methods - After a mean of 4.5 years, respiratory function (forced vital capacity (FVC) and single breath gas transfer factor (TLCO)) and disease activity were reexamined in 13 of 15 previously studied children with SLE. Disease activity was assessed by a validated index of SLE activity (SLE activity measure (SLAM)). Results - In spite of the high prevalence of abnormalities of respiratory function at the baseline investigation, no chest radiographic abnormalities or overt clinical signs oflung disease were found at baseline, in the interval between the two investigations, or at the re-evaluation in any patient. From baseline to the second investigation the mean value of SLAM decreased and there was a trend toward an improvement in FVC and TLCO. TLCO was more severely impaired than FVC, being found as an isolated abnormality in a high percentage of patients (45% at baseline and 35% at follow up). There was a relationship between baseline TLCO and disease activity, expressed as a SLAM score. Moreover, there was a correlation between the changes in the SLAM score from baseline to the second investigation and the corresponding changes in the TLCO value, but not with the corresponding changes in the FVC value. Conclusions - In this series of patients the decrease in SLE activity from the first to the second investigation was associated with an improvement in pulmonary function. The presence of early isolated functional abnormalities was not associated with subsequent development of lung disease.
引用
收藏
页码:424 / 428
页数:5
相关论文
共 50 条
  • [41] Neuropsychiatric Systemic Lupus Erythematosus in Children
    Soybilgic, Arzu
    PEDIATRIC ANNALS, 2015, 44 (06): : E153 - E158
  • [42] Systemic Lupus Erythematosus in Children and Adolescents
    Levy, Deborah M.
    Kamphuis, Sylvia
    PEDIATRIC CLINICS OF NORTH AMERICA, 2012, 59 (02) : 345 - +
  • [43] SYSTEMIC LUPUS-ERYTHEMATOSUS IN CHILDREN
    ROSENBERG, AM
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1994, 16 (2-3): : 261 - 279
  • [44] Systemic lupus erythematosus in Egyptian children
    Salah, Samia
    Lotfy, Hala Mohamed
    Sabry, Samar M.
    El Hamshary, Azza
    Taher, Heba
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (12) : 1463 - 1468
  • [45] Systemic lupus erythematosus in children and adolescents
    Gottlieb, Beth S.
    Ilowite, Norman T.
    PEDIATRICS IN REVIEW, 2006, 27 (09) : 323 - 330
  • [46] Echocardiographic Assessment of Diastolic Function in Children with Incident Systemic Lupus Erythematosus
    Chang, Joyce C.
    White, Brian R.
    Elias, Matthew D.
    Xiao, Rui
    Knight, Andrea M.
    Weiss, Pamela F.
    Mercer-Rosa, Laura
    PEDIATRIC CARDIOLOGY, 2019, 40 (05) : 1017 - 1025
  • [47] Systemic lupus erythematosus in children and adolescents
    Sallmann, S.
    Fiebig, B.
    Hedrich, C. M.
    Heubner, G.
    Gahr, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2006, 65 (07): : 576 - +
  • [48] Belimumab for children with systemic lupus erythematosus
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (09): : E526 - E526
  • [49] SYSTEMIC LUPUS-ERYTHEMATOSUS IN CHILDREN
    GIRARDET, JP
    FONTAINE, JL
    REVUE DE PEDIATRIE, 1978, 14 (01): : 39 - 47
  • [50] Systemic lupus erythematosus in Egyptian children
    Samia Salah
    Hala Mohamed Lotfy
    Samar M. Sabry
    Azza El Hamshary
    Heba Taher
    Rheumatology International, 2009, 29